Previous Article | Next Article ![]()
Infection and Immunity, December 1999, p. 6249-6256, Vol. 67, No. 12
Veterinary Molecular Biology, Montana State University,
Bozeman, Montana 59717-36101; Institute
of Human Virology, University of Maryland Biotechnology Institute,
Baltimore, Maryland 212012;
Immunobiology Vaccine Center and Departments of Microbiology
and Oral Biology, University of Alabama at Birmingham, Birmingham,
Alabama 35294-21703; and Department
of Mucosal Immunology, Research Institute for Microbial
Diseases, Osaka University, Suita, Osaka 565, Japan4
Received 26 July 1999/Accepted 9 September 1999
Protective immunity to enterotoxigenic Escherichia coli
(ETEC) is antibody (Ab) dependent; however, oral immunization with purified ETEC fimbriae fails to elicit protective immunity as a
consequence of antigenic alteration by the gastrointestinal (GI) tract.
Unless unaltered ETEC fimbriae can reach the inductive lymphoid tissues
of the GI tract, immunity to ETEC cannot be induced. To produce
immunity, live vectors, such as Salmonella typhimurium, can
effectively target passenger antigens to the inductive lymphoid tissues
of the GI tract. By convention, oral immunizations with Salmonella vectors induce CD4+ T helper (Th)
cell responses by gamma interferon (IFN-
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Expression of Recombinant Enterotoxigenic
Escherichia coli Colonization Factor Antigen I by
Salmonella typhimurium Elicits a Biphasic T Helper
Cell Response
)-dominated pathways both to
the vector and passenger antigen, resulting in serum immunoglobulin G2a
(IgG2a) and modest mucosal IgA Ab responses. In the present study, mice
orally immunized with a Salmonella vector engineered to
stably express ETEC colonization factor antigen I (CFA/I) showed
initially elevated serum IgG1 and mucosal IgA anti-CFA/I Ab responses.
As expected, mice orally immunized with an E. coli-CFA/I
construct elicited poor anti-CFA/I Ab responses. In fact, the addition
of cholera toxin during oral E. coli-CFA/I immunization
failed to greatly enhance mucosal IgA Ab responses. Seven days after
immunization with the Salmonella-CFA/I construct, cytokine-specific ELISPOT showed induction of predominant Th2-type responses in both mucosal and systemic immune compartments supporting the early IgG1 and IgA anti-CFA/I Abs. By 4 weeks, the Th cell response
became Th1 cell dominant from the earlier Th2-type responses, as
evidenced by increased mucosal and systemic IFN-
-producing T cells
and a concomitant elevation of serum IgG2a Ab responses. This biphasic
response offers an alternative strategy for directing Salmonella vector-induced host immunity along a Th2
cell-dependent pathway, allowing for early promotion of mucosal and
systemic Abs.
*
Corresponding author. Mailing address: Veterinary
Molecular Biology, Montana State University, Bozeman, MT 59717-3610. Phone: (406) 994-6244. Fax: (406) 994-4303. E-mail:
dpascual{at}montana.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|